Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

2.

Asymptomatic or Minimally Symptomatic Myelofibrosis

3.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

4.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

5.

Glofitamab Regimen Improves Survival in DLBCL


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot